Sort by
Refine Your Search
-
Listed
-
Field
-
focuses on understanding how tumour cell plasticity and dynamic cell state transitions drive resistance, and aims to identify actionable vulnerabilities that could inform future therapies. You will work
-
applications. In this role, you will take the lead on an independent project within our broader research programme. Your work will centre on identifying and characterising novel regulators of the immune response
-
in cilia. Transport within cilia, the cell’s signalling and sensory antennae, is central to human biology. It enables these cell-surface organelles to assemble and dynamically change their proteome in
-
Colorectal Cancer - Stratification of Therapies through Adaptive Responses (CRC-STARS) programme, developing and applying cutting-edge mathematical methods to spatial transcriptomics imaging data in order to
-
. The Preston lab is highly interdisciplinary and collaborative and co-located with a dynamic cluster of research groups studying plant biology, microbiology and plant-microbe interactions. You will hold, or be
-
exciting opportunity to join the dynamic research group on Digital Ethics and Defence Technologies, contributing to pioneering work at the forefront of AI and ethics. The role focuses on innovative research
-
About the role We have an exciting opportunity to join the dynamic research group led by Dr Jie Yang in the Department of Oncology at the University of Oxford. The group conducts research on T cell
-
overseeing and implementing the Centre’s programmatic activity related to policy impact, working closely with the Research Programmes Lead to drive the delivery of an integrated and coherent programme of
-
of agentic behaviour and publishing high-impact research. Candidates should possess a PhD (or be near completion) in PhD in Computer Science, AI, Security, or a related field. You will have a Strong background
-
research group has shown, by contrast, that the dynamics of antigenically diverse pathogens is driven by naturally acquired immunity against epitopes of limited variability (ELV), thereby opening up